Thursday, October 8, 2020
12:25 PM EST – Bausch Health Companies Inc. : Provided a preliminary update on its third-quarter 2020 financial results and the pace of its business recovery from the COVID-19 pandemic. Bausch Health expects third-quarter 2020 revenue to be greater than $2.1 billion , which would be a sequential increase of approximately 28% compared to the second quarter of 2020. Reported revenue in the second quarter of 2020 declined 23% compared to the second quarter of 2019, and the Company expects third-quarter 2020 reported revenue to decline approximately 3% compared to the third quarter of 2019. Additionally, based on the pace of recovery of its various businesses observed in the third quarter of 2020 and assuming its businesses continue to rebound from the impact of the COVID-19 pandemic, Bausch Health currently expects its full-year 2020 revenue and Adjusted EBITDA (non-GAAP) to be around the midpoint of its current guidance ranges of $7.80 – $8.00 billion for revenue and $3.15 – $3.30 billion for 2020 Adjusted EBITDA. Bausch Health Companies Inc. (T.BHC) shares were up $2.46 at 23.8.
Stocks in Play: Bausch Health Companies Inc., Thu, 08 Oct 2020 12:30:03 EST